Search

Your search keyword '"Denys, Hannelore"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Denys, Hannelore" Remove constraint Author: "Denys, Hannelore" Topic breast neoplasms Remove constraint Topic: breast neoplasms
26 results on '"Denys, Hannelore"'

Search Results

2. Overall Survival and Exploratory Biomarker Analyses of Abemaciclib plus Trastuzumab with or without Fulvestrant versus Trastuzumab plus Chemotherapy in HR+, HER2+ Metastatic Breast Cancer Patients.

3. Histologic tumor type as a determinant of survival in hormone receptor-positive, HER2-negative, pT1-3 invasive ductal and lobular breast cancer.

4. GRACE-trial: a randomised active-controlled trial for vulvovaginal atrophy in patients with breast cancer on endocrine therapy - study protocol.

5. ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.

6. Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial.

7. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.

8. Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer.

9. Corneal features in trastuzumab emtansine treatment: not a rare occurrence.

10. Corneal Changes in Trastuzumab Emtansine Treatment.

11. Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

12. Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth.

13. The isolation of morphologically intact and biologically active extracellular vesicles from the secretome of cancer-associated adipose tissue.

14. When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer.

15. Resection of single metachronous liver metastases from breast cancer stage I-II yield excellent overall and disease-free survival. Single center experience and review of the literature.

16. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

17. Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

19. Distinguishing score 0 from score 1+ in HER2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance.

20. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.

21. Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.

22. Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations.

23. Use of tamoxifen before and during pregnancy.

24. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.

25. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.

26. A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients.

Catalog

Books, media, physical & digital resources